DNLI·24823R105·US·equity·Healthcare - Biotechnology-13D/G
DNLI (DENALI THERAPEUTICS INC) is held by 132 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($250.3M), BAILLIE GIFFORD & CO ($231.7M), Temasek Holdings (Private) Ltd ($134.6M). Net institutional sentiment: Mixed.
See how DNLI's score breaks down across 4 SEC sources
Showing 1-20 of 145
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer